337,000 Orion Corporation A shares converted into B shares
August 20, 2025 02:00 ET Â | Source: Orion Oyj ORION CORPORATION STOCK…
Darolutamide receives EU approval in third indication for patients with advanced prostate cancer
July 21, 2025 03:30 ET Â | Source: Orion Oyj ORION CORPORATION PRESS…